ISTITUTO ONCOLOGICO VENETO - Italy 

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):900-1000
Networking Rank (Reputation):900-1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 3.139.984 0 1
2012 0 6.000.000 500.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ABBVIE INC1
ACZON1
AQUAMARIJN MICRO FILTRATION BV1
ASPER BIOTECH1
ASTRAZENECA1
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA 'ISTITUTI OSPITALIERI DI VERONA1
AZIENDA ULSS N3 SERENISSIMA1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
CENTRE FOR PROCESS INNOVATION LIMITED LBG1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ELSA SCIENCE AB1
F HOFFMANNLA ROCHE1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HOSPITAL CLINIC DE BARCELONA1
ICU MEDICAL BV1
INSTITUT GUSTAVE ROUSSY1
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL1
LEUKOCARE1
LONZA1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUND UNIVERSITY1
MAGYAR TUDOMANYOS AKADEMIA SZEGEDIBIOLOGIAI KUTATOKOZPONT1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
PFIZER LIMITED1
PLURIMA1
PROBATION LABS SWEDEN AB1
REGION UPPSALA1
REUMATIKERFORBUNDET1
RISE RESEARCH INSTITUTES OF SWEDEN AB1
SANOFIAVENTIS1
SOCIETA ITALIANA DI FARMACIA CLINICA E TERAPIA1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITEIT TWENTE1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF DUNDEE1

Constancy:

Total number of partners: 37
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 37
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-07-01Real World Handling of Protein Drugs - Exploration, Evaluation and Education RealHOPEparticipant3.139.98427
2012-09-01Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients CTCTRAPparticipant6.000.00012